D.E. Shaw & Co
NXGN

D.E. Shaw & Co’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

D.E. Shaw & Co’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-157,415
Closed -$3.74M – 4760
2023
Q3 		$3.74M Sell
157,415
-99,887
-39% -$1.88M ﹤0.01% 2078
2023
Q2 		$4.17M Buy
257,302
+25,652
+11% +$425K ﹤0.01% 2007
2023
Q1 		$4.03M Buy
231,650
+112,387
+94% +$2.02M ﹤0.01% 2129
2022
Q4 		$2.24M Buy
119,263
+89,584
+302% +$1.73M ﹤0.01% 2844
2022
Q3 		$525K Sell
29,679
-37,561
-56% -$652K ﹤0.01% 4016
2022
Q2 		$1.17M Sell
67,240
-90,867
-57% -$1.73M ﹤0.01% 3518
2022
Q1 		$3.31M Sell
158,107
-105,508
-40% -$2.02M ﹤0.01% 2780
2021
Q4 		$4.69M Buy
263,615
+55,953
+27% +$898K ﹤0.01% 2442
2021
Q3 		$2.93M Buy
207,662
+24,465
+13% +$381K ﹤0.01% 2644
2021
Q2 		$3.04M Buy
183,197
+17,317
+10% +$310K ﹤0.01% 2511
2021
Q1 		$3M Sell
165,880
-117,459
-41% -$2.32M ﹤0.01% 2231
2020
Q4 		$5.17M Sell
283,339
-93,465
-25% -$1.48M ﹤0.01% 1845
2020
Q3 		$4.8M Sell
376,804
-33,349
-8% -$426K ﹤0.01% 1726
2020
Q2 		$4.5M Buy
410,153
+170,748
+71% +$1.77M 0.01% 1725
2020
Q1 		$2.5M Buy
239,405
+45,564
+24% +$588K ﹤0.01% 1992
2019
Q4 		$3.12M Buy
193,841
+39,979
+26% +$661K ﹤0.01% 2121
2019
Q3 		$2.41M Sell
153,862
-9,288
-6% -$154K ﹤0.01% 2221
2019
Q2 		$3.25M Sell
163,150
-77,150
-32% -$1.44M ﹤0.01% 1908
2019
Q1 		$4.04M Sell
240,300
-14,499
-6% -$251K 0.01% 1678
2018
Q4 		$3.86M Sell
254,799
-45,182
-15% -$775K 0.01% 1682
2018
Q3 		$6.02M Buy
299,981
+21,158
+8% +$449K 0.01% 1451
2018
Q2 		$5.44M Buy
278,823
+7,953
+3% +$126K 0.01% 1477
2018
Q1 		$3.7M Sell
270,870
-66,303
-20% -$874K 0.01% 1607
2017
Q4 		$4.58M Buy
337,173
+32,601
+11% +$468K 0.01% 1541
2017
Q3 		$4.79M Sell
304,572
-48,485
-14% -$783K 0.01% 1403
2017
Q2 		$6.08M Buy
353,057
+30,127
+9% +$458K 0.01% 1206
2017
Q1 		$4.92M Buy
322,930
+99,828
+45% +$1.47M 0.01% 1312
2016
Q4 		$2.93M Buy
223,102
+35,901
+19% +$460K 0.01% 1722
2016
Q3 		$2.12M Sell
187,201
-101,517
-35% -$1.22M ﹤0.01% 1885
2016
Q2 		$3.44M Buy
288,718
+13,100
+5% +$176K 0.01% 1532
2016
Q1 		$4.2M Buy
275,618
+124,543
+82% +$1.89M 0.01% 1389
2015
Q4 		$2.44M Buy
+151,075
New +$2.21M ﹤0.01% 1982
2015
Q2 		– Sell
-24,398
Closed -$390K – 3914
2015
Q1 		$390K Sell
24,398
-44,146
-64% -$730K ﹤0.01% 3188
2014
Q4 		$1.07M Buy
68,544
+7,005
+11% +$102K ﹤0.01% 2781
2014
Q3 		$847K Buy
+61,539
New +$934K ﹤0.01% 2948
2014
Q2 		– Sell
-11,917
Closed -$188K – 4608
2014
Q1 		$201K Buy
+11,917
New +$216K ﹤0.01% 4084

Other funds holding NXGN

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's NXGN Position: Q4 2023 in Review

D.E. Shaw & Co sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 157,415 shares — an estimated $3.74M sold.

D.E. Shaw & Co first reported a position in NXGN in Q1 2014 and held it in 36 quarters. The position peaked at $6.08M in Q2 2017. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • D.E. Shaw & Co reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 157,415 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $3.74M.
  • D.E. Shaw & Co first reported a position in NextGen Healthcare, Inc. Common Stock in Q1 2014 and held it in 36 quarters.
  • D.E. Shaw & Co's NextGen Healthcare, Inc. Common Stock position peaked at $6.08M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.